Hara Kazuo, Yamauchi Toshimasa, Kadowaki Takashi
Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Tokyo 113-8655, Japan.
Curr Diab Rep. 2005 Apr;5(2):136-40. doi: 10.1007/s11892-005-0041-0.
Adipocyte-derived adiponectin is an insulin-sensitizing and antiatherosclerotic hormone, and replenishment of adiponectin in animal models ameliorated insulin resistance and atherosclerosis. In humans, recent studies have demonstrated that adiponectin level is a good predictor of developing type 2 diabetes and coronary artery disease. Decreasing level of adiponectin is caused by the interaction between genetic factors, such as single nucleotide polymorphisms in the adiponectin gene, and environmental factors, such as high-fat diet. Agents that increase blood level of adiponectin or enhance the actions of adiponectin can be an ideal medicine for ameliorating insulin resistance and type 2 diabetes.
脂肪细胞分泌的脂联素是一种具有胰岛素增敏和抗动脉粥样硬化作用的激素,在动物模型中补充脂联素可改善胰岛素抵抗和动脉粥样硬化。在人类中,最近的研究表明脂联素水平是2型糖尿病和冠状动脉疾病发生的良好预测指标。脂联素水平降低是由遗传因素(如脂联素基因中的单核苷酸多态性)和环境因素(如高脂饮食)之间的相互作用引起的。提高血液中脂联素水平或增强脂联素作用的药物可能是改善胰岛素抵抗和2型糖尿病的理想药物。